- 全部删除
您的购物车当前为空
Oxaprozin potassium 是具有口服活性的COX 的抑制剂,其对人血小板COX-1 的IC50值为 2.2 μM,对 IL-1 刺激的人类滑膜细胞COX-2的IC50值为 36 μM。Oxaprozin potassium 诱导细胞凋亡。Oxaprozin potassium 还抑制 NF-κB 活化,Oxaprozin potassium 介导的Akt/IKK/NF-κB 通路抑制有助于其抗炎特性。

Oxaprozin potassium 是具有口服活性的COX 的抑制剂,其对人血小板COX-1 的IC50值为 2.2 μM,对 IL-1 刺激的人类滑膜细胞COX-2的IC50值为 36 μM。Oxaprozin potassium 诱导细胞凋亡。Oxaprozin potassium 还抑制 NF-κB 活化,Oxaprozin potassium 介导的Akt/IKK/NF-κB 通路抑制有助于其抗炎特性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 1-2周 | |
| 50 mg | ¥ 13,800 | 1-2周 | |
| 100 mg | ¥ 17,500 | 1-2周 |
Oxaprozin potassium 相关产品
| 产品描述 | Oxaprozin potassium is an orally active and potent inhibitor of COX, with IC 50 values of 2.2 μM and 36 μM for human platelet COX-1 and for IL-1-stimulated human synovial cell COX-2, respectively. Oxaprozin potassium induces cell apoptosis. Oxaprozin potassium also inhibits the NF-κB activation. Oxaprozin potassium-mediated inhibition of the Akt/IKK/NF-κB pathway contributes to its anti-inflammatory properties [1] [2]. |
| 靶点活性 | COX-2:36 μM, COX-1:2.2 μM |
| 体外活性 | Oxaprozin (0-100 μM) induces apoptosis in a dose-dependent manner. Oxaprozin increases caspase-3 activity in the activated but not in the resting condition. NF-κB activation is inhibited by Oxaprozin (50 μM). Oxaprozin inhibits activation of the IKK system induced by the reagent IκBα [1]. Oxaprozin (100 μM) induces the strongest proapoptotic effect and significantly increases CD40L-treated monocyte apoptosis. Oxaprozin treatment inhibits CD40L-induced Akt and NF-κB (p65) phosphorylation [2]. |
| 分子量 | 331.412 |
| 分子式 | C18H14KNO3 |
| CAS No. | 174064-08-5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容